We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Third Case of Rare Nervous System Disease Linked to Tysabri
Third Case of Rare Nervous System Disease Linked to Tysabri
April 8, 2005
Biogen Idec and Elan confirmed March 30 that their multiple sclerosis (MS) drug Tysabri has been linked to a third case of a deadly central nervous system disorder — news that analysts believe could close the door on the drug’s potential return to the market.